SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Caroline M. Piskun, Timothy J. Stein, β-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour, Veterinary and Comparative Oncology, 2016, 14, 1
  2. 2
    Kaishan Ye, Shuanke Wang, Yong Yang, Xuewen Kang, Jing Wang, Hua Han, Aplasia Ras homologue member Ⅰ overexpression�inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture, International Journal of Molecular Medicine, 2015,

    CrossRef

  3. 3
    Patricia C. Valery, Mathieu Laversanne, Freddie Bray, Bone cancer incidence by morphological subtype: a global assessment, Cancer Causes & Control, 2015, 26, 8, 1127

    CrossRef

  4. 4
    Wenfang Guo, Wenli Hao, Maolin Du, Zhuang Su, Yuelin Hu, Yuan Xia, Xiong Su, Juan Sun, Bone Cancer Mortality in Inner Mongolia from 2008 to 2012, Open Journal of Epidemiology, 2015, 05, 01, 59

    CrossRef

  5. 5
    K. E. Holmes, V. Thompson, C. M. Piskun, R. A. Kohnken, M. K. Huelsmeyer, T. M. Fan, T. J. Stein, Canine osteosarcoma cell lines from patients with differing serum alkaline phosphatase concentrations display no behavioural differences in vitro, Veterinary and Comparative Oncology, 2015, 13, 3
  6. 6
    Xiaolong Yu, Xin Zhou, Changlin Fu, Qiang Wang, Tao Nie, Fan Zou, Runsheng Guo, Hucheng Liu, Bin Zhang, Min Dai, Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway, Oncology Reports, 2015,

    CrossRef

  7. 7
    P DelaGarza-Montano, E Estrada-Villasenor, R Dominguez Rubio, V Martinez-Lopez, A Avila-Luna, A Alfaro-Rodriguez, D Garciadiego-Cazares, A Carlos, AD Hernandez-Perez, C Bandala, Epidemiological Aspects of Osteosarcoma, Giant Cell Tumor and Chondrosarcoma Musculoskeletal Tumors - Experience of the National Rehabilitation Institute, Mexico City, Asian Pacific Journal of Cancer Prevention, 2015, 16, 15, 6451

    CrossRef

  8. 8
    V. R. Lo Vasco, M. Leopizzi, C. Della Rocca, Ezrin-related Phosphoinositide pathway modifies RhoA and Rac1 in human osteosarcoma cell lines, Journal of Cell Communication and Signaling, 2015, 9, 1, 55

    CrossRef

  9. 9
    L. Mirabello, M. Yeager, P. L. Mai, J. M. Gastier-Foster, R. Gorlick, C. Khanna, A. Patino-Garcia, L. Sierrasesumaga, F. Lecanda, I. L. Andrulis, J. S. Wunder, N. Gokgoz, D. A. Barkauskas, X. Zhang, A. Vogt, K. Jones, J. F. Boland, S. J. Chanock, S. A. Savage, Germline TP53 Variants and Susceptibility to Osteosarcoma, JNCI Journal of the National Cancer Institute, 2015, 107, 7, djv101

    CrossRef

  10. 10
    Fei Zhang, Wei Huang, Meixia Sheng, Tielong Liu, MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients, Tumor Biology, 2015, 36, 3, 2041

    CrossRef

  11. 11
    Juan Yao, Yaguang Weng, Shujuan Yan, Mengyi Hou, Hao Wang, Qiong Shi, Guowei Zuo, NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways, Oncology Reports, 2015,

    CrossRef

  12. 12
    Max Brosa, Xavier García del Muro, Jaume Mora, Alba Villacampa, Tamara Pozo-Rubio, Laia Cubells, Carmen Montoto, Orphan drugs revisited: cost–effectiveness analysis of the addition of mifamurtide to the conventional treatment of osteosarcoma, Expert Review of Pharmacoeconomics & Outcomes Research, 2015, 15, 2, 331

    CrossRef

  13. 13
    G M O’Kane, K A Cadoo, E M Walsh, R Emerson, P Dervan, C O’Keane, B Hurson, G O’Toole, S Dudeney, E Kavanagh, S Eustace, D N Carney, Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review, Clinical Sarcoma Research, 2015, 5, 1

    CrossRef

  14. 14
    Özge Uluçkan, Aude Segaliny, Sander Botter, Janice M Santiago, Anthony J Mutsaers, Preclinical mouse models of osteosarcoma, BoneKEy Reports, 2015, 4, 670

    CrossRef

  15. 15
    Xinyu Wu, Zhida Chen, Wengrong Zeng, Yuanfu Zhong, Qingjun Liu, Jin Wu, Silencing ofEag1Gene Inhibits Osteosarcoma Proliferation and Migration by Targeting STAT3-VEGF Pathway, BioMed Research International, 2015, 2015, 1

    CrossRef

  16. 16
    Dumnoensun Pruksakorn, Areerak Phanphaisarn, Olarn Arpornchayanon, Nantawat Uttamo, Taninnit Leerapun, Jongkolnee Settakorn, Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital, Cancer Epidemiology, 2015, 39, 6, 956

    CrossRef

  17. 17
    Ninna Aggerholm-Pedersen, Katja Maretty-Nielsen, Johnny Keller, Steen Baerentzen, Henrik Schrøder, Peter Holmberg Jørgensen, Bjarne Hauge Hansen, Ole Steen Nielsen, Akmal Safwat, The importance of standardized treatment in high-grade osteosarcoma: 30 years of experience from a hospital-based database, Acta Oncologica, 2015, 54, 1, 17

    CrossRef

  18. 18
    Kjetil Berner, Tom Børge Johannesen, Aasmund Berner, Hans Kristian Haugland, Bodil Bjerkehagen, Per J. Bøhler, Øyvind S. Bruland, Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma, Acta Oncologica, 2015, 54, 1, 25

    CrossRef

  19. 19
    Romain Guiho, Kevin Biteau, Dominique Heymann, Françoise Redini, TRAIL-based therapy in pediatric bone tumors: how to overcome resistance, Future Oncology, 2015, 11, 3, 535

    CrossRef

  20. 20
    Carl R. Walkley, Bone Cancer, 2015,

    CrossRef

  21. 21
    Q. Tian, J. Jia, S. Ling, Y. Liu, S. Yang, Z. Shao, A causal role for circulating miR-34b in osteosarcoma, European Journal of Surgical Oncology (EJSO), 2014, 40, 1, 67

    CrossRef

  22. 22
    Richard B. Richardson, Age-specific bone tumour incidence rates are governed by stem cell exhaustion influencing the supply and demand of progenitor cells, Mechanisms of Ageing and Development, 2014, 139, 31

    CrossRef

  23. 23
    Maria V. Guijarro, Steven C. Ghivizzani, C. Parker Gibbs, Animal Models in Osteosarcoma, Frontiers in Oncology, 2014, 4,

    CrossRef

  24. 24
    Anthony J. Mutsaers, Carl R. Walkley, Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?, Bone, 2014, 62, 56

    CrossRef

  25. 25
    Wanli Ma, Xuhua Zhang, Jie Chai, Peng Chen, Peng Ren, Mingzhi Gong, Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma, Tumor Biology, 2014, 35, 12, 12467

    CrossRef

  26. 26
    Worawut Choeyprasert, Samart Pakakasama, Nongnuch Sirachainan, Duantida Songdej, Ampaiwan Chuansumrit, Usanarat Anurathapan, Suradej Hongeng, Adisak Nartthanarung, Comparative Outcome of Thai Pediatric Osteosarcoma Treated with Two Protocols: the Role of High-Dose Methotrexate (HDMTX) in a Single Institute Experience, Asian Pacific Journal of Cancer Prevention, 2014, 15, 22, 9823

    CrossRef

  27. 27
    V. R. Lo Vasco, M. Leopizzi, C. Puggioni, C. Della Rocca, Ezrin silencing remodulates the expression of Phosphoinositide-specific Phospholipase C enzymes in human osteosarcoma cell lines, Journal of Cell Communication and Signaling, 2014, 8, 3, 219

    CrossRef

  28. 28
    Qingbing Meng, Jie Zhao, Hongbing Liu, Guoyou Zhou, Wensheng Zhang, Xingli Xu, Minqian Zheng, HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma, Tumor Biology, 2014, 35, 12, 12265

    CrossRef

  29. 29
    Giun-Yi Hung, Jiun-Lin Horng, Hsiu-Ju Yen, Chueh-Chuan Yen, Wei-Ming Chen, Paul Chih-Hsueh Chen, Hung-Ta Hondar Wu, Hong-Jen Chiou, Incidence Patterns of Primary Bone Cancer in Taiwan (2003–2010): A Population-Based Study, Annals of Surgical Oncology, 2014, 21, 8, 2490

    CrossRef

  30. 30
    Huiwen Liu, Lu Huang, Zhongzu Zhang, Zhanming Zhang, Zhiming Yu, Xiang Chen, Zhuo Chen, Yongping Zen, Dong Yang, Zhimin Han, Yong Shu, Min Dai, Kai Cao, LIM Mineralization Protein-1 Inhibits the Malignant Phenotypes of Human Osteosarcoma Cells, International Journal of Molecular Sciences, 2014, 15, 4, 7037

    CrossRef

  31. 31
    Caroline Hadley, Loyola V. Gressot, Akash J. Patel, Lisa L. Wang, Ricardo J. Flores, William E. Whitehead, Thomas G. Luerssen, Andrew Jea, Robert J. Bollo, Osteosarcoma of the cranial vault and skull base in pediatric patients, Journal of Neurosurgery: Pediatrics, 2014, 13, 4, 380

    CrossRef

  32. 32
    Worawut Choeyprasert, Rungrote Natesirinilkul, Pimlak Charoenkwan, Somjai Sittipreechacharn, Carboplatin and Doxorubicin in Treatment of Pediatric Osteosarcoma: A 9-year Single Institute Experience in the Northern Region of Thailand, Asian Pacific Journal of Cancer Prevention, 2013, 14, 2, 1101

    CrossRef

  33. 33
    Richard Gorlick, Katherine Janeway, Stephen Lessnick, R. Lor Randall, Neyssa Marina, Children's Oncology Group's 2013 blueprint for research: Bone tumors, Pediatric Blood & Cancer, 2013, 60, 6
  34. 34
    C.A. Stiller, A. Trama, D. Serraino, S. Rossi, C. Navarro, M.D. Chirlaque, P.G. Casali, Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project, European Journal of Cancer, 2013, 49, 3, 684

    CrossRef

  35. 35
    Vincenza Rita Lo Vasco, Martina Leopizzi, Caterina Chiappetta, Chiara Puggioni, Claudio Di Cristofano, Carlo Della Rocca, Expression of Phosphoinositide-specific phospholipase C enzymes in human osteosarcoma cell lines, Journal of Cell Communication and Signaling, 2013, 7, 2, 141

    CrossRef

  36. 36
    Jeremy Lewin, Ajay Puri, Richard Quek, Roger Ngan, Ana Patricia Alcasabas, David Wood, David Thomas, Management of sarcoma in the Asia-Pacific region: resource-stratified guidelines, The Lancet Oncology, 2013, 14, 12, e562

    CrossRef

  37. 37
    Lifeng Liu, Ying Xu, Russel J. Reiter, Melatonin inhibits the proliferation of human osteosarcoma cell line MG-63, Bone, 2013, 55, 2, 432

    CrossRef

  38. 38
    Haixia Zhang, Haotong Wu, Junheng Zheng, Pei Yu, Lixiao Xu, Pan Jiang, Jin Gao, Hua Wang, Yan Zhang, Transforming Growth Factor β1 Signal is Crucial for Dedifferentiation of Cancer Cells to Cancer Stem Cells in Osteosarcoma, STEM CELLS, 2013, 31, 3
  39. 39
    Yucai Wang, Jun Chen, Dianzhong Zhang, Yunfei Zhang, Yanhua Wen, Lihong Li, Lianhe Zheng, Tumoricidal effects of a selenium (Se)-polysaccharide from Ziyang green tea on human osteosarcoma U-2 OS cells, Carbohydrate Polymers, 2013, 98, 1, 1186

    CrossRef

  40. 40
    George T. Calvert, R. Lor Randall, Kevin B. Jones, Lisa Cannon-Albright, Stephen Lessnick, Joshua D. Schiffman, At-Risk Populations for Osteosarcoma: The Syndromes and Beyond, Sarcoma, 2012, 2012, 1

    CrossRef

  41. 41
    Sarah K. Gray, Meghan E. McGee-Lawrence, Jennifer L. Sanders, Keith W. Condon, Chung-Jui Tsai, Seth W. Donahue, Black bear parathyroid hormone has greater anabolic effects on trabecular bone in dystrophin-deficient mice than in wild type mice, Bone, 2012, 51, 3, 578

    CrossRef

  42. 42
    Santosh S. Dhule, Patrice Penfornis, Trivia Frazier, Ryan Walker, Joshua Feldman, Grace Tan, Jibao He, Alina Alb, Vijay John, Radhika Pochampally, Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma, Nanomedicine: Nanotechnology, Biology and Medicine, 2012, 8, 4, 440

    CrossRef

  43. 43
    J E Davies, S Neidle, D G Taylor, Developing and paying for medicines for orphan indications in oncology: utilitarian regulation vs equitable care?, British Journal of Cancer, 2012, 106, 1, 14

    CrossRef

  44. 44
    Pingxian Tan, Changye Zou, Bicheng Yong, Ju Han, Longjuan Zhang, Qiao Su, Junqiang Yin, Jin Wang, Gang Huang, Tingsheng Peng, Jingnian Shen, Expression and prognostic relevance of PRAME in primary osteosarcoma, Biochemical and Biophysical Research Communications, 2012, 419, 4, 801

    CrossRef

  45. 45
    Li-Min Yang, Xiu-Hua Li, Cui-Fen Bao, Glutathione S-transferase P1 and DNA Polymorphisms with the Response to Chemotherapy and the Prognosis of Bone Tumor, Asian Pacific Journal of Cancer Prevention, 2012, 13, 11, 5883

    CrossRef

  46. 46
    Jeremy Whelan, Anne McTiernan, Nicola Cooper, Yuen K Wong, Matthew Francis, Sally Vernon, Sandra J. Strauss, Incidence and survival of malignant bone sarcomas in England 1979–2007, International Journal of Cancer, 2012, 131, 4
  47. 47
    Pattara Wiromrat, Arunee Jetsrisuparb, Patcharee Komvilaisak, Winai Sirichativapee, Supot Kamsa-Ard, Surapon Wiangnon, Incidence and Survival Rates among Pediatric Osteogenic Sarcoma Cases in Khon Kaen, Thailand, 1985-2010, Asian Pacific Journal of Cancer Prevention, 2012, 13, 9, 4281

    CrossRef

  48. 48
    Pui Yan Jenny Chung, Wim Van Hul, Paget's Disease of Bone: Evidence for Complex Pathogenetic Interactions, Seminars in Arthritis and Rheumatism, 2012, 41, 5, 619

    CrossRef

  49. 49
    Cristiana Capriani, Dinaz Irani, John P Bilezikian, Safety of osteoanabolic therapy: A decade of experience, Journal of Bone and Mineral Research, 2012, 27, 12
  50. 50
    Lisa Mirabello, Kai Yu, Sonja I Berndt, Laurie Burdett, Zhaoming Wang, Salma Chowdhury, Kedest Teshome, Arinze Uzoka, Amy Hutchinson, Tom Grotmol, Chester Douglass, Richard B Hayes, Robert N Hoover, Sharon A Savage, A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma, BMC Cancer, 2011, 11, 1, 209

    CrossRef

  51. 51
    Andrea Y. Angstadt, Alison Motsinger-Reif, Rachael Thomas, William C. Kisseberth, C. Guillermo Couto, Dawn L. Duval, Dahlia M. Nielsen, Jaime F. Modiano, Matthew Breen, Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: Signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart, Genes, Chromosomes and Cancer, 2011, 50, 11
  52. 52
    Jakob K. Anninga, Hans Gelderblom, Marta Fiocco, Judith R. Kroep, Antoni H.M. Taminiau, Pancras C.W. Hogendoorn, R. Maarten Egeler, Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?, European Journal of Cancer, 2011, 47, 16, 2431

    CrossRef

  53. 53
    Harry Comber, Sandra Deady, Erin Montgomery, Anna Gavin, Drinking water fluoridation and osteosarcoma incidence on the island of Ireland, Cancer Causes & Control, 2011, 22, 6, 919

    CrossRef

  54. 54
    Lisa Mirabello, Ruth Pfeiffer, Gwen Murphy, Najat C. Daw, Ana Patiño-Garcia, Rebecca J. Troisi, Robert N. Hoover, Chester Douglass, Joachim Schüz, Alan W. Craft, Sharon A. Savage, Height at diagnosis and birth-weight as risk factors for osteosarcoma, Cancer Causes & Control, 2011, 22, 6, 899

    CrossRef

  55. 55
    Sharon A. Savage, Lisa Mirabello, Using Epidemiology and Genomics to Understand Osteosarcoma Etiology, Sarcoma, 2011, 2011, 1

    CrossRef

  56. 56
    Katherine A. Janeway, Carl R. Walkley, Modeling human osteosarcoma in the mouse: From bedside to bench, Bone, 2010, 47, 5, 859

    CrossRef

  57. 57
    Richard Gorlick, Chand Khanna, Osteosarcoma, Journal of Bone and Mineral Research, 2010, 25, 4
  58. 58
    Jennifer Worch, Katherine K. Matthay, John Neuhaus, Robert Goldsby, Steven G. DuBois, Osteosarcoma in children 5 years of age or younger at initial diagnosis, Pediatric Blood & Cancer, 2010, 55, 2
  59. 59
    Sameer Bakhshi, Venkatraman Radhakrishnan, Prognostic markers in osteosarcoma, Expert Review of Anticancer Therapy, 2010, 10, 2, 271

    CrossRef

  60. 60
    Colin Moore, Don Eslin, Alejandro Levy, Jessica Roberson, Vincent Giusti, Robert Sutphin, Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma, Pediatric Blood & Cancer, 2010, 55, 6
  61. 61
    Robert Grimer, Nick Athanasou, Craig Gerrand, Ian Judson, Ian Lewis, Bruce Morland, David Peake, Beatrice Seddon, Jeremy Whelan, UK Guidelines for the Management of Bone Sarcomas, Sarcoma, 2010, 2010, 1

    CrossRef

  62. 62
    Elizabeth J. Davis, Geoffrey Siegel, Mary Feng, J. Sybil Biermann, Rashmi Chugh, Bone (osteosarcoma),
  63. 63
    Lisa Mirabello, Osteosarcoma: Genetics of Inherited Susceptibility, eLS,